Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
May 31 2023 - 11:40AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of May 2023
Commission File Number: 001-31995
MEDICURE INC. |
(Translation of registrant’s name into English) |
2-1250 Waverley Street
Winnipeg, MB Canada R3T 6C6
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
EXHIBIT LIST
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Medicure Inc. | |
| (Registrant) | |
| | | |
Date: May 26, 2023 | By: | /s/ Dr. Albert D. Friesen | |
| | Dr. Albert D. Friesen | |
| Title: | CEO | |
| | | |
Medicure (PK) (USOTC:MCUJF)
Historical Stock Chart
From Nov 2024 to Dec 2024
Medicure (PK) (USOTC:MCUJF)
Historical Stock Chart
From Dec 2023 to Dec 2024